281 related articles for article (PubMed ID: 21614411)
1. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
2. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor.
Bartok A; Steiner S; Seidinger D; Jetzl A; Huber K; Minar E; Stefenelli T; Kopp CW
Thromb Res; 2005; 115(6):469-74. PubMed ID: 15792677
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
5. Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.
Mobarrez F; Egberg N; Antovic J; Bröijersen A; Jörneskog G; Wallén H
Thromb Res; 2012 Jan; 129(1):95-7. PubMed ID: 22035651
[No Abstract] [Full Text] [Related]
6. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.
Tehrani S; Mobarrez F; Antovic A; Santesson P; Lins PE; Adamson U; Henriksson P; Wallén NH; Jörneskog G
Thromb Res; 2010 Sep; 126(3):e225-31. PubMed ID: 20637495
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin and its collateral effects on microparticles.
Montoro-García S; Lip GY; Shantsila E
Thromb Haemost; 2011 Aug; 106(2):185-6. PubMed ID: 21614421
[No Abstract] [Full Text] [Related]
8. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
[TBL] [Abstract][Full Text] [Related]
9. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
[TBL] [Abstract][Full Text] [Related]
10. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
Bruni F; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Cercigani M; Leo A; Auteri A; Puccetti L
Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
Ni R; Peleg T; Gross PL
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
15. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
17. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
19. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
[TBL] [Abstract][Full Text] [Related]
20. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Serebruany VL; Midei MG; Malinin AI; Oshrine BR; Lowry DR; Sane DC; Tanguay JF; Steinhubl SR; Berger PB; O'Connor CM; Hennekens CH
Arch Intern Med; 2004 Oct; 164(18):2051-7. PubMed ID: 15477442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]